SPARK is a free online study with a simple mission: to speed up research and advance the understanding of autism. By building a community of tens of thousands of individuals with autism and their biological family members who provide behavioral and genetic data, SPARK will be the largest autism research study to date.
Participation in SPARK can be done entirely at home — register online here.
Find out more about what’s involved on our SPARK page.
Questions? Contact Samantha Hunter at 573-882-6479 or firstname.lastname@example.org.
The purpose of this study is to validate the ability of a salivary RNA panel (diagnostic test) to differentiate children diagnosed with Autism Spectrum Disorder (ASD) from those with developmental delays. This study will help to further aid in diagnosing individuals with ASD.
The purpose of this study is to investigate how propranolol—a drug generally prescribed for high blood pressure—might improve social communication in those with autism. We will also be looking into possible relationships between autism symptoms and how well someone responds to propranolol.
The purpose of this study is to learn more about how a medication called minocycline could be used to treat some impairments related to Autism Spectrum Disorder. Minocycline is an antibiotic that is currently used for the treatment of acne.
The purpose of this study is to validate the ability of a remote eye gaze tracker to differentiate children diagnosed with Autism Spectrum Disorder (ASD) to those with developmental delays. We will also be looking at how well eye gaze correlates with autism symptom severity and language ability.